Text size
Personal Survey

About Amylin-Lilly

Sharing a commitment to people with diabetes

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company created an alliance in 2002 to collaborate on the development and commercialization of unique therapeutic solutions that improve the lives of people with type 2 diabetes.

Amylin Pharmaceuticals, Inc. — Founded in 1987

Eli Lilly and Company — Founded in 1876

Amylin: http://www.amylin.com/contactus.cfm
Lilly: http://www.lilly.com/contact.html

Important Safety Information

  • BYETTA improves blood glucose (blood sugar) control in adults with type 2 diabetes. It is used with metformin, a sulfonylurea, or a thiazolidinedione.
  • BYETTA is not a substitute for insulin in patients whose diabetes requires insulin treatment.
  • Before using BYETTA, tell your healthcare provider about all of your medical conditions, including if you have severe problems with either your stomach or food digestion; if you have severe kidney disease; or if you are pregnant, plan to become pregnant, or are breastfeeding.
  • When BYETTA is used with a medicine that contains a sulfonylurea, hypoglycemia (low blood sugar) is a possible side effect. The dose of your sulfonylurea medicine may need to be reduced while you use BYETTA.
  • Other common side effects with BYETTA include nausea, vomiting, diarrhea, dizziness, headache, feeling jittery, and acid stomach. Nausea is most common when first starting BYETTA, but decreases over time in most patients.
  • If you experience the following severe and persistent symptoms (alone or in combination): abdominal pain, nausea, vomiting, or diarrhea, contact your healthcare provider because they could be signs of serious medical conditions.
  • BYETTA may reduce your appetite, the amount of food you eat, and your weight. No changes in your BYETTA dose are needed for these side effects.
  • These are not all the possible side effects from use of BYETTA. Talk to your healthcare provider about any side effect that bothers you or that does not go away.
  • BYETTA improves blood glucose (blood sugar) control in adults with type 2 diabetes. It is used with metformin, a sulfonylurea, or a thiazolidinedione.
  • BYETTA is not a substitute for insulin in patients whose diabetes requires insulin treatment.
  • Before using BYETTA, tell your healthcare provider about all of your medical conditions, including if you have severe problems with either your stomach or food digestion; if you have severe kidney disease; or if you are pregnant, plan to become pregnant, or are breastfeeding.
  • When BYETTA is used with a medicine that contains a sulfonylurea, hypoglycemia (low blood sugar) is a possible side effect. The dose of your sulfonylurea medicine may need to be reduced while you use BYETTA.
  • Other common side effects with BYETTA include nausea, vomiting, diarrhea, dizziness, headache, feeling jittery, and acid stomach. Nausea is most common when first starting BYETTA, but decreases over time in most patients.
  • If you experience the following severe and persistent symptoms (alone or in combination): abdominal pain, nausea, vomiting, or diarrhea, contact your healthcare provider because they could be signs of serious medical conditions.
  • BYETTA may reduce your appetite, the amount of food you eat, and your weight. No changes in your BYETTA dose are needed for these side effects.
  • These are not all the possible side effects from use of BYETTA. Talk to your healthcare provider about any side effect that bothers you or that does not go away.

Click here to see the complete BYETTA Patient Product Information.

Prescribing Information | Patient Information | Important Safety Information | Site Map | Contact Us | Diabetes Glossary